Benzophenones as xanthine oxidase inhibitors

Anticancer Research

Volumn 19, Issue 2 A, 1999, Pages 1131-1135

  Sheu, Shiow Yunn ^a   Tsai, Hsing Jane ^b   Chiang, Hsüch Ching ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

2,2',4,4' Tetrahydroxybenzophenone; 3,4,5,2',3'4' Hexahydroxybenzophenone; Aldose reductase inhibitor; Antithrombotic; Cognitive enhancing agent; Sunscreen agent; Xanthine oxidase inhibitors

Indexed keywords

ALLOPURINOL; BENZOPHENONE DERIVATIVE; EXIFONE; QUERCETIN; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; ENZYME INHIBITION; PRIORITY JOURNAL;

BENZOPHENONES; ENZYME INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP; XANTHINE OXIDASE;

EID: 0033061744     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Budavari S: The Merck Index 12th ed. pp.1125, NJ; Merck & Co., Inc., 1996.
2. Elks J and Ganellin CR: Dictionary of Drugs p.413, 569, 628, 1238, etc. London and New York, Chapman and Hall, 1990.
3. Chang WS, Lee YJ, Lu FJ and Chiang HC: Inhibitory effects of flavonoids on xanthine oridase. Anticancer Res 13: 2165-2170, 1993.
4. Chang WS, Chang YH, Lu FJ and Chiang HC: Inhibitory effects of phenolics on xanthine oridase. Anticancer Res 14: 501-506, 1994.
5. Chang WS, Wen PC and Chinag HC: Structure-activity relationship of caffeic acid analogues on xanthine oxidase inhibition. Anticancer Res 15: 703-708, 1995.
6. Chang WS and Chiang HC: Structure-activity relationship of coumarins in xanthine oxidase inhibition. Anticancer Res 15: 1969-1974, 1995.
7. Chang WS, Yan GF and Chiang HC: Inhibitory effects of phenolic carboxylic acid analogues on xanthine oxidase. Anticancer Res 15: 2097-2100, 1995.
8. Chiang HC, Lo YJ and Lu FJ: Xanthine oxidase inhibitors from the leaves of Alsophila spinulosa (Hook) Tryon. J Enzyme Inhib 8(1): 61-71, 1994.
9. Sheu SY and Chiang HC: Inhibition of xanthine oxidase by hydroxylated anthraquinones and related compounds. Anticancer Res 17: 3293-3296, 1997.
10. Sheu SY, Lai CH and Chiang HC: Inhibition of xanhtine oxidase by purpurogallin and silymarin group. Anticancer Res 18: 263-268, 1998.
11. Sheu SY and Chiang HC: Inhibitory effects of plant growth regulators on xanthine oxidase. Anticancer Res 16: 311-315, 1996.
12. Sheu SY, Lin YC and Chiang HC: Inhibition of xanthine oxidase by cytokinins and related substances. Anticancer Res 16: 3571-3576, 1996.
13. Sheu SY, Lin YC and Chiang HC: Inhibition of xanthine oxidase by synthetic cytokinin analogues. Anticancer Res 17: 1043-1050, 1997.
14. Colowick SP and Kaplan NO: Methods in Enzymology. Vol. 74. Immunochemical Techniques. Part C edited by Langone JJ and Vanakis HV. In: (Halfman CJ ed), Section II. Data analysis. Chapter 32. Concentrations of binding proteins and labeled analyte that are appropriate for measuring at any analyte concentration range in radioimmunoassays. Pp. 481-497, and (Ukraincik K and Piknosh W eds), Chapter 33, Microprocessor-based radioimmunoassay data analysis. New York; Academic Press Inc 1981, pp.497-508.
15. Colowick SP and Kaplan NO: Methods in Enzymology. Vol. 74. Immunochemical Techniques. Part C edited by Langone JJ and Vanakis HV. In: (Halfman CJ ed), Section II. Data analysis. Chapter 32. Concentrations of binding proteins and labeled analyte that are appropriate for measuring at any analyte concentration range in radioimmunoassays. Pp. 481-497, and (Ukraincik K and Piknosh W eds), Chapter 33, Microprocessor-based radioimmunoassay data analysis. New York; Academic Press Inc 1981, pp.497-508.
16. Colowick SP and Kaplan NO: Methods in Enzymology. Vol. 74. Immunochemical Techniques. Part C edited by Langone JJ and Vanakis HV. In: (Halfman CJ ed), Section II. Data analysis. Chapter 32. Concentrations of binding proteins and labeled analyte that are appropriate for measuring at any analyte concentration range in radioimmunoassays. Pp. 481-497, and (Ukraincik K and Piknosh W eds), Chapter 33, Microprocessor-based radioimmunoassay data analysis. New York; Academic Press Inc 1981, pp.497-508.
17. Lineweaver H and Burk D: The determination of enzyme dissociation constants. J Am Chem Soc 56: 658-666, 1934.
18. nd ed. In: Chapter 4. Enzyme. Enzyme inhibition, p. 250, competitive inhibition; p. 260, uncompetitive inhibition; p. 261, mixed type inhibition. New York, John Wiley and Sons, 1976.
19. Ono H and Hayano S: 2,2',4,4'-tetrahydroxybenzophenone as a new aldose reductase inhibitor. Nippon Ganka Gakkai Zasshi-Acta Societatis Ophthalmological Japonicae 86: 353-357, 1982.
20. Porsolt RD, Lenegre A, Avril I, Lancrenon S, Steru L and Doumont G: Psychopharmacological profile of the new cognition enhancing agent exifone in the mouse. Arzneim-Forsch/ Drug Res 37: 388-393, 1987.
21. Porsolt RD, Lenegre A, Avril I and Doumont G: Antagonism by exifone, a new cognitive enhancing agent, of the amnesias induced by four benzodiazepines in mice. Psychopharmacol 95: 291-297, 1988.
22. Allain H, Denmat J, Bentue-Ferrer D, Milon D, Pignol P, Reymann JM, Pape D, Sabourand and Van den Driessche J: Randomized, double-blind trial of exifone versus cognitive problems in Parkinson's disease. Fundam Clin Pharmacol 2: 1-12, 1988.
23. Porsolt RD, Lenegre A, Avril I, Steru L and Doumont G: The Effects of exifone, a new agent for senil memory disorder, on two models of memory in the mouse. Pharmacol Biochem Behav 27: 253-256, 1987.
24. Cardozo-Pelaez F, Song S, Parthasarathy A, Epstein CJ and Sanchez-Ramos J: Attenuation of age-dependent oxidative damage to DNA and protein in brainstem of Tg Cu/Zn SOD Mice. Neurobiol Aging 19: 311-316, 1998.
25. Alam ZI, Jenner A, Daniel SE, Less AJ, Cairns N, Marsden CD, Jenner P and Halliwell B: Oxidative DNA damage in the Parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 69: 1196-1203, 1997.
26. Sanchez-Ramos J, Overvik E and Ames BN: A marker of oxyradical-mediated DNA damage (8-hydroxy-2'deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain. Neurodegeneration 3: 197-204, 1994.
27. Chiricolo M, Tazzari PL, Abbondanza A, Dinota A and Battelli MG: Cytotoxicity of, and DNA damage by, active oxygen species produced byxanthineoxidase. FEBS Lett 291: 173-176, 1991.
28. Bentue-Ferrer D, Philouze V, Pape D, Reymann JM, Allain H and Van Den Driessche J: Comparative evaluation of scavenger properties of exifone, piracetam and vinburnine. Fundam Clin Pharmacol 3: 323-328, 1989.
29. Burkart V, Koike T, Brenner HH and Kolb H: Oxygen radicals generated by the enzyme xanthine oxidase lyse rat pancreatic islet cells in vitro. Diabetologia 35: 1028-1034, 1992.
30. McCord JM: Oxygen-derived free radicals in poatischaemic tissue damage. New Engl J Med 312: 159-163, 1985.
31. Saugstad OD: Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Ped Res 23: 143-150, 1988.
32. Halliwell B, Borish ET, Pryor WA, Ames B, Saul RL, McCord JM and Harman D: Oxygen radicals and human disease. Ann Intern Med 107: 526-545, 1987.
33. Sakurai K and Ogiso T: Studies on the biological damage by active oxygen. 111. Generation of hydroxyl radical and inhibition of insulin release in hypoxanthine-xanthine oxidase system in the presence of panreatic islet cells. Yakugaku Zasshi 109: 102-106, 1989.
34. Weiss SJ: Oxygen, ischaemia and inflammation. Acta Phys Scand (Suppl) 548: 937, 1986.
35. -. generation system of hypoxanthine-xanthine oxidase . Yakugaku Zasshi 108: 150-155, 1988.